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Ovarian hyperstimulation syndrome (OHSS) presents in ∼33% of ovarian stimulation cycles with clinical manifestations varying
from mild to severe. Its pathogenesis is unknown. Pleural eﬀusion is reported in ∼10% of severe OHSS cases and is usually
associated with marked ascites. The isolated ﬁnding of pleural eﬀusions without ascites, as the main presenting symptom of OHSS
is not frequently reported and its pathogenesis is also unknown. We describe two unusual cases of OHSS where dyspnea secondary
to unilateral pleural eﬀusion was the only presenting symptom. By reporting our experience, we would like to heighten physicians’
awareness in detecting these cases early, as it is our belief that the incidence of pleural eﬀusion in the absence of most commonly
recognized risk factors for OHSS may be underestimated and may signiﬁcantly compromise the health of the patient if treatment
is not initiated in a reasonable amount of time.
1.Background
Ovarian hyperstimulation syndrome (OHSS) presents in
∼33% of ovarian stimulation cycles with clinical manifes-
tations varying from mild to severe [1]. Its pathogenesis
is unknown, but the main pathophysiology is an increase
of vascular permeability and third spacing, leading to
hemoconcentration and inadequate end organ perfusion.
Severe OHSS symptoms include massive ovarian enlarge-
ment with multiple cysts, rapid weight gain, and third space
sequestration. Although the incidence of severe OHSS may
be underreported at 0.5–0.96% [2–4], it still can be life
threatening as a result of its potential to progress to adult
respiratory distress syndrome, renal failure, hepatic injury,
hemostatic imbalances, and thromboembolic episodes.
Pleural eﬀusion is reported in ∼10% of severe OHSS
cases and is usually associated with marked ascites [5, 6].
When there is signiﬁcant ascites, it has been proposed
that diaphragmatic lymphatics provide a route for the
transfer of the ascitic ﬂuid into the right pleural space
since the right side of the chest contains the thoracic duct,
the main channel for lymphatic drainage from the lower
parts of the body [7]. The isolated ﬁnding of pleural
eﬀusions without ascites, as the main presenting symptom
of OHSS, is not frequently reported [6]. A Canadian study
reported an incidence of 0.65% (5/771 patients stimulated
with gonadotropins) with only one patient requiring a
thoracentesis (1/771, 0.12%) [8]. The pathophysiology of
isolatedpleuraleﬀusioninOHSScasesisalsounknown.One
hypothesis is that the pleural eﬀusion occurs as a result of
mildly increased intra-abdominal pressure that drives ascitic
ﬂuid through weak diaphragmatic anatomical defects. When
these defects rupture, the negative intrathoracic pressure
preferentially allows for the ascites to permeate through
these open channels and enter the pleural space. These
defects are more commonly seen on the right side of the
diaphragm [9] and have been observed via laparoscopy,
openthoracotomy,andpostmortemasmultiplemacroscopic
defects of thin membranes covering the tendinous portion of
the diaphragm [5, 10].
By reporting our experience, we would like to heighten
physicians’ awareness in detecting these cases early, as it is2 Case Reports in Obstetrics and Gynecology
ourbeliefthattheincidenceofpleuraleﬀusionintheabsence
of more commonly recognized risk factors for OHSS may be
underestimated.
1.1. Case 1. A 25-year-old G0 woman with no signiﬁcant
past medical history or physical ﬁndings other than poly-
cystic ovaries on ultrasound enrolled in our Ooctye Donor
Program. Downregulation was achieved using OCPs and
depot leuprolide acetate 3.75 intramuscularly on day 21.
Ovarian stimulation was initiated with 225IU of human
menopausal gonadotropin (hMG) for 5 days. This dose was
taperedasaresultofthepatient’sovarianresponse,measured
by ultrasound and estradiol levels. She received a total of
1975IU of hMG over 9 days and 500µg of r-hCG when two
follicles reached a 17mm diameter; her peak estradiol level
was 3,731pmol/L. A total of 44 oocytes were retrieved.
The patient initially presented 2 days after oocyte retriev-
al with complaints of dyspnea on exertion and a 2-pound
weight gain. She denied nausea, vomiting, or abdominal
distention. She was afebrile but tachycardic. Her lungs were
clear on auscultation, abdomen was slightly distended with
mildtendernessintheleftlowerquadrant.Ultrasoundevalu-
ation demonstrated no evidence of intraperitoneal ﬂuid, and
ovaries were enlarged bilaterally (left: 56 × 89mm; right:
48 × 81mm) consistent with moderate hyperstimulation.
She had normal electrolytes and renal function, hematocrit
was 0.44%; she was initially managed as an outpatient
with oral hydration and modiﬁed activity. Her symptoms
progressed such that by POD #12, she presented with a 5-
pound weight gain and nonproductive cough. Her pulse
was 118bpm and saturating 97% on room air. On physical
examination, breath sounds were absent in ∼66% of the
posterior right lung ﬁeld. Her abdomen remained slightly
distended, and on ultrasound, there was still no evidence of
intraperitoneal ﬂuid. A chest X-ray (CXR) conﬁrmed a large
right pleural eﬀusion (Figure 1). Spiral CT scan was negative
for pulmonary embolism (PE) or deep venous thrombosis
(DVT) and conﬁrmed a minimal amount of abdominal
ascites. Thoracentesis was performed; 2600cc clear yellow
ﬂuid was initially suctioned oﬀ with a total of 2900cc over 48
hours.Totalﬂuidproteinwas37g/L,whichisconsistentwith
exudates. Pleural ﬂuid culture was negative. She was placed
on low molecular weight heparin (LMWH) and sequential
compression devices (SCDs) for DVT prophylaxis.
During her 2-day hospital admission, her dyspnea and
nonproductive cough resolved. On day of discharge her CXR
showed resolution of the pleural eﬀusion, and, subsequently,
the chest tube was removed without complications. She
returned to our oﬃce 3 days after hospital discharge with a
9-pound weight loss and complete resolution of symptoms.
The patient was followed closely as an outpatient with serial
chest X-rays; she fully recovered without further sequelae.
1.2. Case 2. A 41-year-old G3P1011 woman with no signiﬁ-
cant past medical history presented for IVF-preimplantation
geneticscreening(PGS)forfamilybalancingafterconceiving
her ﬁrst child, without complications, with ovulation induc-
tion using gonadotropins and intrauterine insemination.
Controlled ovarian hyperstimulation was performed using
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an antagonist protocol with daily injections of 300IU
of recombinant follicle-stimulating hormone (rFSH) and
150IU of hMG. 250µg of Ganirelix Acetate injection was
started on day 9 and continued for 4 days. 10,000units
of hCG intramuscularly were given when two lead follicles
reached 18mm. The patient received a total of 2550IU of
FSH and 1350IU of hMG over 9 days. Her peak estradiol
was 2552pmol/L. 18 oocytes were retrieved. Two genetically
normal embryos were transferred. Daily intramuscular pro-
gesterone was given for luteal phase supplementation.
Fourteendaysafteroocyteretrieval,thepatientpresented
with complaints of nausea and bloating. Serum pregnancy
test was positive. Her physical examination was signiﬁcant
for a 3-pound weight gain since the day of oocyte retrieval.
She was tachycardic but saturating 98% on room air. Her
abdomen was slightly distended and tender. Lung ﬁelds were
clear to auscultation bilaterally. Ultrasound demonstrated
minimal free intraperitoneal ﬂuid, and ovaries measured
50 × 48mm and 66 × 37mm. Laboratory assessment was
signiﬁcant for normal electrolytes and renal function;
hematocrit was 48.4%. The patient was initially managed
conservatively as an outpatient with oral hydration and
modiﬁedactivity.However,lessthan12hoursafterherinitial
evaluation, the patient subsequently developed shortness of
breath and chest pain and was admitted to the hospital.
Her physical exam was signiﬁcant for tachypnea and labored
breathing with signiﬁcantly decreased breath sounds from
∼66% of the posterior right lung ﬁeld. Repeat ultrasound
evaluation demonstrated no evidence of free intraperitoneal
ﬂuid. CXR demonstrated a moderate right sided pleural
eﬀusion (Figure 2). Thoracentesis was performed; 2600cc
clear yellow ﬂuid was initially suctioned oﬀ via pleurovac
with a total drainage of 2750cc over 3 days. Total ﬂuid
protein was 42g/L, consistent with an exudative pleural
eﬀusion. Bacterial culture and ﬂuid cytology were negative.
She was placed on LMWH for DVT prophylaxis. The
patient’scoursewascomplicatedbyseveralepisodesofsevere
pleuritic chest pain requiring removal of chest tube on
hospital day 2. A CT scan was performed which was negative
for a PE. Her clinical symptoms resolved upon removal of
the chest tube despite a residual small right pleural eﬀusion
on CXR. The patient was discharged home on hospital day 3Case Reports in Obstetrics and Gynecology 3
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with a hematocrit of 41, which had decreased from a peak
level of 48. Her serum sodium normalized at 136meq/L
after rising from a nadir of 130meq/L. Serum beta hCG was
134mIU/mL on day 28 and rose appropriately.
Two days after discharge, she began to experience
worsening chest pain and shortness of breath. A repeat
CXR demonstrated a large right pleural eﬀusion which
was signiﬁcantly larger in comparison to prior CXR. The
patient was readmitted to the hospital due to the sever-
ity of symptoms. A CT scan to rule out a PE and an
echocardiogram to rule out underlying cardiac disease were
both negative. The patient underwent a second thoracentesis
with drainage of 2100cc over the next 4 days. The pleural
ﬂuid analysis was consistent with an exudate and again
demonstrated no malignant cells on cytology and negative
bacterial culture. The patient experienced hyponatremia
to a nadir of 130meq/L which gradually resolved with
intravenous normal saline treatment. On hospital day 5,
the chest tube drainage was minimal (70cc), and a chest
X-ray demonstrated a signiﬁcant improvement in pleural
eﬀusion. The chest tube was discontinued, and the patient
was discharged home on hospital day 6.
The patient was followed as an outpatient with gradual
resolution of pleuritic chest pain and no further compli-
cations. A twin intrauterine pregnancy was documented
by ultrasound on cycle day 46. Despite one of the fetuses
spontaneously miscarrying, the patient subsequently had an
uncomplicated singleton pregnancy and delivered a healthy
male infant at term.
2. Conclusion
OHSS usually results from stimulation of the ovaries by
gonadotropins with the initial onset following the adminis-
tration ofexogenous hCG. Womenatparticularly higherrisk
include those with the following characteristics: younger age,
polycystic ovaries, low BMI, rapidly rising serum estradiol
level, and an elevated peak estradiol level [11]. OHSS has
traditionally been classiﬁed as mild, moderate, or severe.
Mild manifestations of OHSS are relatively common in
ART and include transient lower abdominal discomfort,
mild nausea, vomiting, diarrhea, and abdominal distention.
Progression of the illness is recognized when symptoms
persist, worsen, or include ascites that may be demonstrated
by increasing abdominal girth or ultrasound evaluation.
Symptoms generally resolve within 1 to 2 weeks but become
more severe and persist longer if pregnancy is successful.
Since the ﬁrst case of isolated pleural eﬀusion associated
with severe OHSS was described in 1975, there have been
few other published case reports [4, 5, 12–27]. We describe
two unusual cases of OHSS where unilateral pleural eﬀusion
was the presenting symptom. Patient number 1’s case is
the ﬁrst described case to present as early as 2 days after
oocyteretrievalwithsymptomsofdyspnea.Priortoourcase,
the earliest described presentation was 6 days after oocyte
retrieval [20]. Patient number 2’s case is remarkable in that
it is only the second case to be described in a woman over 40
years of age; the ﬁrst was described in 2007 [21].
Complaints of dyspnea within the ﬁrst few days after
oocyte retrieval in the absence of intra-abdominal ascites
should raise the physician’s clinical suspicion of isolated
pleural eﬀusion. In these cases, a chest X-ray should be
included in addition to the standard workup for OHSS.
Physicians should not be misled in thinking that dyspnea
is only a direct result of increased intra-abdominal pressure
in the setting of OHSS, especially when ultrasound ﬁndings
reveal low intra-abdominal ﬂuid volumes. If a pleural eﬀu-
sion is diagnosed, then appropriate treatment may include
drainage by thoracocentesis. This procedure was used safely
in these two cases, which led to reversal of symptoms and an
improvement in clinical status.
In summary, as the number of IVF cycles performed
increases, it is important to make physicians aware of this
veryrealandperhapsunderestimatedcomplicationofOHSS,
as pleural eﬀusions may signiﬁcantly compromise the health
of the patient if treatment is not initiated in a reasonable
amount of time.
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